A Supreme Court ruling gives drug companies more leeway to conduct research using patented substances from competitors.
Justices today unanimously reversed a lower court ruling in favor of a patent-holder (Integra LifeSciences Holdings Corporation).
It means big drug companies have more flexibility to start experimenting with potential therapies as long as they won't be marketed until a competitor's patent expires.
The patent-holder had accused a German company of infringing on a patent on certain molecules. Researchers hope the patented biological molecules can inhibit tumors.
|Get the ingredients you need to cook with Rach all week long.|
|Full length exclusive concerts from hot artists.|
|Take a break!
Classic Pacman, Frogger, Asteroids and more.
Sell almost anything locally.